IDCRC members, Kirsten E. Lyke and Igho Ofotokun elected to
the National Academy of Medicine
The Leadership Group would like to recognize and congratulate IDCRC members, Kirsten E. Lyke, MD, professor of medicine, Center for Vaccine Development and Global Health, and director, Malaria Vaccine and Challenge Unit, University of Maryland School of Medicine, Baltimore; IDCRC Malaria/Tropical Diseases Expert Working Group member; and Igho Ofotokun, MD, Grady Distinguished professor of medicine, School of Medicine, and professor of behavioral, social, and health education sciences, Rollins School of Public Health, Emory University; IDCRC Leadership Group Education and Training Committee chair; for being elected to the National Academy of Medicine.
On October 9, 2023, The National Academy of Medicine (NAM) announced the election of 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health.
About the National Academy of Medicine
Founded in 1970 as the Institute of Medicine (IOM), the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States. Operating under the 1863 Congressional charter of the National Academy of Sciences, the National Academies are private, nonprofit institutions that work outside of government to provide objective advice on matters of science, technology, and health.
The NAM has more than 2,400 members elected in recognition of professional achievement and commitment to volunteer service in activities of the National Academies of Sciences, Engineering, and Medicine (the National Academies). The NAM elects no more than 90 regular members and 10 international members annually. For those at the top of their field, NAM membership reflects the height of professional achievement and commitment to service.
About Infectious Disease Clinical Research Consortium (IDCRC)
This activity is supported by the Infectious Diseases Clinical Research Consortium (IDCRC) through the NIAID (UM1AI148684). The IDCRC, consisting of the Vaccine Treatment and Evaluation Units (VTEUs) and the IDCRC Leadership Group, was formed in 2019 to support the planning and implementation of infectious diseases clinical research that efficiently addresses the scientific priorities of NIAID. The consortium includes infectious diseases leaders and clinical researchers from Emory University, University of Maryland School of Medicine, Baylor College of Medicine, Cincinnati Children’s Medical Center and University of Cincinnati, FHI360, Fred Hutchinson Cancer Research Center, Johns Hopkins University, Kaiser Permanente Washington Health Research Institute, New York University, Saint Louis University, Vanderbilt University Medical Center, University of Alabama at Birmingham,
University of Rochester, University of Washington, and NIAID. For more information about the IDCRC, please visit www.IDCRC.org.